CD117+ cells/telocytes in chronic steatohepatitis and hepatitis C virus infection: histotopographic and quantitative features.

Authors

  • E. M. Gavrilyuk Danylo Halytsky Lviv National Medical University, Ukraine

DOI:

https://doi.org/10.26641/1997-9665.2016.3.89-93

Keywords:

CD117 cells/telocytes, chronic steatohepatitis, hepatitis C virus infection

Abstract

Background. The course of the most common chronic liver diseases depends on the balance in fibrosis and reparative regeneration. Interrelations between these processes depend on many factors, including recently described cellular type CD117+ cells/telocytes which are involved in paracrine regulation. Objective. The aim is to study histotopographic and quantitative features of CD117+ cells/telocytes in chronic steatohepatitis and hepatitis C virus infection. Methods. 20 autopsies with diagnosed alcoholic steatohepatitis, nonalcoholic steatohepatitis and viral hepatitis C (fibrosis stage 2-3, METAVIR) were enrolled in this study. The CD117+ cells/telocytes were evaluated in the liver tissue. Marker quantification was performed by assessing the ratio of stained tissue to the total area of the liver section using image analysis. Differences between groups were analyzed using Student’s t-test; p < 0,05 was considered as significant. Results. Microscopic examination shows presence of CD117+ cells/telocytes in the interstitial compartment, mostly at the margin between the parenchyma and fibrous tissue – an area associated with “stem cell niche”. Such localization confirms the idea about regulatory role of CD117+ cells/telocytes in liver fibrosis and regeneration, which depends on direct intercellular contacts and paracrine effects. Evaluation of CD117+ cells/telocytes area in the liver section shows the higher degree in chronic steatohepatitis group (1,98±0,25) than in patients with hepatitis С virus infection (1,15±0,4) (p > 0,05). Conclusion. Differences in the amount of CD117+ cells/telocytes in the area of “stem cell niche” in patients with chronic steatohepatitis and hepatitis C virus infection correlates with the hypothesis about existence of multiple pathogenetic pathways of fibrosis and regeneration which depends on the etiologic factors or secondary influences induced during the course of the disease.

References

  1. Popesku LM, Faussone-Pellegrini MS. Telocytes – a case of serendipity: the winding way from interstitial cells of cajal (icc), via interstitial cajal-like cells (ICLC) to telocytes. J Cell Mol Med. 2010;14:729-40.
  2. Xiao J, Wang F, Liu Z, Yang C. Telocytes in liver: electron microscopic and immunofluorescent evidence. J Cell Mol Med. 2013;17(12):1537-42.
  3. Nizyaeva NV, Shchegolev AI, Marey MV, Suchich GT. [Interstitial Pacemaker Cells]. Annals of the Russian Academy of Medical Sciences. 2014;7–8:17–24.
  4. Cretoiu SM, Popesku LM. Telocytes revisited. Biomol Concepts. 2014;5(5):353-69.
  5. Wang F, Song Y, Bei Y, Zhao Y, Xiao J, Yang C. Telocytes in liver regeneration: possible roles. J Cell Mol Med. 2014;18:1720-6.
  6. Bei Y, Wang F, Yang C, Xiao J. Telocytes in regenerative medicine. J Cell Mol Med. 2015;19(7):1441-54.
  7. Boos AM, Weigand A, Brodbeck R, Beier JP, Arkudas A, Horch RE. The potential role of telocytes in Tissue Engineering and Regenerative Medicine. Semin Cell Dev Biol. 2016;55:70-8.
  8. Bedossa P., Poynard T. An algorithm for grading activity in chronic hepatitis C. The French METAVIR Cooperative Study Group. Hepatology. 1996;24:289-93.
  9. Brunt EM, Tiniakos DG. Histopathology of nonalcoholic fatty liver disease. World J Gastroenterol. 2010;16(42):5286-96.
  10. Mirancea N. Telocyte - a particular cell phenotype. Infrastructure, relationships and putative functions. Rom J Morphol Embryol. 2016;57(1):7-21.
  11. Dabbs D., author. Diagnostic Immunohisto-chemistry. Theranostic and genomic application. 3rd ed. New-York: Saunders Elsevier; 2010. 1452 p.
  12. Zheng Y, Bai C, Wang X. Telocyte mor-phologies and potential roles in diseases. J Cell Physiol. 2012;227(5):2311-7.
  13. Ibba-Manneschi L, Rosa I, Manetti M. Telocyte implications in human pathology: An over-view. Semin Cell Dev Biol. 2016;55:62-9.
  14. Díaz-Flores L, Gutiérrez R, Díaz-Flores LJr, Gomez MG, Saez FJ, Madrid JF. Behaviour of telocytes during physiopathological activation. Semin Cell Dev Biol. 2016;55:50-61.
  15. Liu J, Cao Y, Song Y, Huang Q, Wang F, Yang W, Yang C. Telocytes in Liver. Curr Stem Cell Re Ther. 2016;11(5):415-9.
  16. Fu S, Wang F, Yang C, Xiao J. Telocytes in human liver fibrosis. J. Cell. Mol. Med. 2015;19(3):676-83.
  17. Lee YA, Wallace MC, Friedman SL, Pathobiology of liver fibrosis: a translation success story. Gut. 2015;64(5):830-41.

How to Cite

Gavrilyuk, E. M. (2016). CD117+ cells/telocytes in chronic steatohepatitis and hepatitis C virus infection: histotopographic and quantitative features. Морфологія / Morphologia / Morfologìâ, 10(3), 89–93. https://doi.org/10.26641/1997-9665.2016.3.89-93

Issue

Section

Статті